Development of a SARS-CoV-2 spike protein binding assay using human epithelial cells for COVID-19 therapy discovery and development

Willcox, Benjamin (Co-Investigator)
Dafforn, Tim (Co-Investigator)
Barnes, Nicholas (Principal Investigator)
Stamataki, Zania (Co-Investigator)

Short title	Development of a SARS-CoV-2 spike protein binding assay using human epithelial cells for COVID-19 therapy discovery and development
Status	Finished
Effective start/end date	1/01/21 → 30/06/22

Funding

TECHNOLOGY STRATEGY BOARD

1 Article

A cell-based, SARS-CoV-2 spike protein interaction assay to inform the neutralising capacity of recombinant and patient sera antibodies
Harrison, N., Richardson, L., Pallini, C., Morano, I., Jinks, E., Cowley, J., Chan, H., Hill, H. J., Tuekprakhon, A., Li, Z., Matas de las Heras, C., Teodosio, A., Lavado, A. S., Moring, R., Ashraf, A., Dafforn, T. R., Grammatopoulos, D. K., Gordon, J., Brady, C. A., Young, L. S., & 3 othersBarnes, N. M., Stamataki, Z. & Qureshi, O. S., 29 Aug 2023, In: Frontiers in Virology. 3, 12 p., 1163385.
Research output: Contribution to journal › Article › peer-review

Open Access
File
33 Downloads (Pure)